Shanghai, China

Weimin Hu

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weimin Hu. Retrieved from https://idiyas.com/inventor/weimin-hu-b5cauf53

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weimin Hu: Innovator in Pharmaceutical Chemistry

Introduction

Weimin Hu is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of therapeutic agents.

Latest Patents

Weimin Hu holds a patent for a fused pyridine ring derivative, which is represented by the general formula (I). This patent includes a preparation method for the derivative, a pharmaceutical composition containing it, and its use as a therapeutic agent. Specifically, this invention is aimed at the preparation of drugs for preventing and/or treating HIV infection. He has 1 patent to his name.

Career Highlights

Throughout his career, Weimin Hu has worked with prominent companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. These experiences have allowed him to apply his innovative ideas in practical settings.

Collaborations

Weimin Hu has collaborated with several professionals in his field, including Xiaomin Zhang and Feng He. Their joint efforts have contributed to advancements in pharmaceutical research and development.

Conclusion

Weimin Hu's work in pharmaceutical chemistry exemplifies the impact of innovation in healthcare. His contributions, particularly in the fight against HIV, highlight the importance of research and development in improving medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…